12 research outputs found
O Design Universal Para Apprendizagem e a Pedagogia das Estacoes: As Multiplas Temporalidades / Espacialidades do Aprender nas Escolas.
This article explores school inclusion processes, with a view to problematizing the learning hegemonies of time and space in educational institutions. It presents partial results of the research project; 'A Escola Para Todos' (The School for All) and responds to the question: How can Universal Design for Learning (UDL), which is somewhat similar to the 'pedagogy of the seasons,' qualify inclusive experiences in schools? By providing an integrative review of the salient features of UDL and pedagogy of the seasons, the paper questions the hegemony of time-space teaching and learning in schools by drawing on narrative theory. Methodologically, this part of the research provides an integrated reflection on critical conceptual attributes incorporating; UDL, the temporalities and spatialities of learning, and concepts of inclusive education. The results of this stage of the research show that it is necessary to overcome the hegemony of time and linear space in learning and teaching processes in order to arrive at school inclusion. Despite similarities between UDL and 'pedagogy of the seasons' tensions remain between these approaches. Not least as reflected in the overcoming of paradoxes such as the necessity to address universal requirements while also tending to particular learner requirements, or equally, while recognizing the variability of strategies without losing sight of more global pedagogical approaches. This challenge is accentuated when the UDL concept of 'expert learners' is further interrogated
The Impact of Adherence to Screening Guidelines and of Diabetes Clinics Referral on Morbidity and Mortality in Diabetes
Despite the heightened awareness of diabetes as a major health problem, evidence on the impact of assistance and organizational factors, as well as of adherence to recommended care guidelines, on morbidity and mortality in diabetes is scanty. We identified diabetic residents in Torino, Italy, as of 1st January 2002, using multiple independent data sources. We collected data on several laboratory tests and specialist medical examinations to compare primary versus specialty care management of diabetes and the fulfillment of a quality-of-care indicator based on existing screening guidelines (GCI). Then, we performed regression analyses to identify associations of these factors with mortality and cardiovascular morbidity over a 4 year- follow-up. Patients with the lowest degree of quality of care (i.e. only cared for by primary care and with no fulfillment of GCI) had worse RRs for all-cause (1.72 [95% CI 1.57â1.89]), cardiovascular (1.74 [95% CI 1.50â2.01]) and cancer (1.35 [95% CI 1.14â1.61]) mortality, compared with those with the highest quality of care. They also showed increased RRs for incidence of major cardiovascular events up to 2.03 (95% CI 1.26â3.28) for lower extremity amputations. Receiving specialist care itself increased survival, but was far more effective when combined with the fulfillment of GCI. Throughout the whole set of analysis, implementation of guidelines emerged as a strong modifier of prognosis. We conclude that management of diabetic patients with a pathway based on both primary and specialist care is associated with a favorable impact on all-cause mortality and CV incidence, provided that guidelines are implemented
Micromechanical Properties of Injection-Molded StarchâWood Particle Composites
The micromechanical properties of injection molded starchâwood particle composites were investigated as a function of particle content and humidity conditions.
The composite materials were characterized by scanning electron microscopy and X-ray diffraction methods. The microhardness
of the composites was shown to increase notably with the concentration of the wood particles. In addition,creep behavior under the indenter and temperature dependence
were evaluated in terms of the independent contribution of the starch matrix and the wood microparticles to the hardness value. The influence of drying time on the density
and weight uptake of the injection-molded composites was highlighted. The results revealed the role of the mechanism of water evaporation, showing that the dependence of water uptake and temperature was greater for the starchâwood composites than for the pure starch sample. Experiments performed during the drying process at 70°C indicated that
the wood in the starch composites did not prevent water loss from the samples.Peer reviewe
Overview of the EUROfusion Tokamak Exploitation programme in support of ITER and DEMO
Within the 9th European Framework programme, since 2021 EUROfusion is operating five tokamaks under the auspices of a single Task Force called âTokamak Exploitationâ. The goal is to benefit from the complementary capabilities of each machine in a coordinated way and help in developing a scientific output scalable to future largre machines. The programme of this Task Force ensures that ASDEX Upgrade, MAST-U, TCV, WEST and JET (since 2022) work together to achieve the objectives of Missions 1 and 2 of the EUROfusion Roadmap: i) demonstrate plasma scenarios that increase the success margin of ITER and satisfy the requirements of DEMO and, ii) demonstrate an integrated approach that can handle the large power leaving ITER and DEMO plasmas. The Tokamak Exploitation task force has therefore organized experiments on these two missions with the goal to strengthen the physics and operational basis for the ITER baseline scenario and for exploiting the recent plasma exhaust enhancements in all four devices (PEX: Plasma EXhaust) for exploring the solution for handling heat and particle exhaust in ITER and develop the conceptual solutions for DEMO. The ITER Baseline scenario has been developed in a similar way in ASDEX Upgrade, TCV and JET. Key risks for ITER such as disruptions and run-aways have been also investigated in TCV, ASDEX Upgrade and JET. Experiments have explored successfully different divertor configurations (standard, super-X, snowflakes) in MAST-U and TCV and studied tungsten melting in WEST and ASDEX Upgrade. The input from the smaller devices to JET has also been proven successful to set-up novel control schemes on disruption avoidance and detachment
ĐĐĐŻĐĄĐĐźĐĐĐĐŹĐĐ ĐĐĐĐĐĄĐĐ ĐșĐČĐ°Đ»ŃŃŃĐșĐ°ŃŃĐčĐœĐŸŃ ŃĐŸĐ±ĐŸŃĐž баĐșалаĐČŃĐ° ŃŃŃĐŽĐ”ĐœŃĐ° ĐĐ°ŃĐłĐ°ĐœĐŸĐČĐ°_ĐĐŒĐžŃŃĐ°_ĐĐŒĐžŃŃĐŸĐČĐžŃĐ° ĐœĐ°ĐżŃŃĐŒŃ ĐżŃĐŽĐłĐŸŃĐŸĐČĐșĐž 124 ĐĄĐžŃŃĐ”ĐŒĐœĐžĐč Đ°ĐœĐ°Đ»ŃĐ·
ĐбâŃĐșŃ ĐŽĐŸŃĐ»ŃĐŽĐ¶Đ”ĐœĐœŃ â ĐżŃĐŽĐżŃĐžŃĐŒŃŃĐČĐŸ ĐĐĐšĐР«ХĐПХКĐĐ Đ· ĐșŃĐœĐœĐŸĐłĐŸ ŃĐżĐŸŃŃŃ» ĐĐĐ .
ĐŃĐ”ĐŽĐŒĐ”Ń ĐŽĐŸŃĐ»ŃĐŽĐ¶Đ”ĐœĐœŃ â ĐżŃĐžĐłĐŸŃŃĐČĐ°ĐœĐœŃ ĐșĐŸŃĐŒŃĐČ ĐŽĐ»Ń ĐłĐŸĐŽŃĐČĐ°ĐœĐœŃ ŃŃĐ”ĐœĐŸĐČĐ°ĐœĐžŃ
Ń ŃĐżĐŸŃŃĐžĐČĐœĐžŃ
ĐșĐŸĐœĐ”Đč.
ĐĐ”ŃĐ° ĐŽĐŸŃĐ»ŃĐŽĐ¶Đ”ĐœĐœŃ: ĐŸĐżŃĐžĐŒŃĐ·Đ°ŃŃŃ ĐČĐžŃŃĐ°Ń ĐżŃĐŽĐżŃĐžŃĐŒŃŃĐČĐ° ŃĐ»ŃŃ
ĐŸĐŒ ŃĐŽĐŸŃĐșĐŸĐœĐ°Đ»Đ”ĐœĐœŃ ŃĐ”Ń
ĐœĐŸĐ»ĐŸĐłŃĐč ĐČĐžŃĐŸĐ±ĐœĐžŃŃĐČĐ° Ń ŃĐ”ŃДпŃŃĐČ ĐșĐŸŃĐŒŃĐČ ĐŽĐ»Ń ŃŃĐ”ĐœĐŸĐČĐ°ĐœĐžŃ
Ń ŃĐżĐŸŃŃĐžĐČĐœĐžŃ
ĐșĐŸĐœĐ”Đč, ĐżŃĐŽĐČĐžŃĐ”ĐœĐœŃ ŃŃ
ŃĐșĐŸŃŃŃ ŃĐ° Đ·ĐœĐžĐ¶Đ”ĐœĐœŃ ĐżĐžŃĐŸĐŒĐžŃ
ĐČĐžŃŃĐ°Ń ĐœĐ° ĐČĐžŃĐŸĐ±ĐœĐžŃŃĐČĐŸ.
ĐĐ”ŃĐŸĐŽĐž ĐŽĐŸŃĐ»ŃĐŽĐ¶Đ”ĐœĐœŃ: ĐŒĐ”ŃĐŸĐŽĐž багаŃĐŸĐșŃĐžŃĐ”ŃŃĐ°Đ»ŃĐœĐŸŃ ŃĐ° ĐœĐ”ŃŃŃĐșĐŸŃ ĐŸĐżŃĐžĐŒŃĐ·Đ°ŃŃŃ
ĐĐșĐŸĐœĐŸĐŒŃŃĐœĐ° Đ”ŃĐ”ĐșŃĐžĐČĐœŃŃŃŃ: ĐŸŃŃĐșŃŃŃŃŃŃ ĐżĐŸĐ·ĐžŃĐžĐČĐœĐŸŃ Đ·Đ°ĐČĐŽŃĐșĐž ŃĐŸĐ·ŃĐŸĐ±ŃŃ ĐŸĐżŃĐžĐŒĐ°Đ»ŃĐœĐžŃ
ĐșĐŸŃĐŒĐŸĐČĐžŃ
ŃŃĐŒŃŃĐ”Đč, ŃĐșŃ ĐŽĐŸĐ·ĐČĐŸĐ»ŃŃŃŃ ĐŸŃŃĐžĐŒŃĐČĐ°ŃĐž бŃĐ»ŃŃĐ” ĐșĐŸŃĐžŃŃŃ ĐŽĐ»Ń ĐșĐŸĐœĐ”Đč ŃĐ° Đ·ĐœĐžĐ·ĐžŃĐž ĐČĐžŃŃĐ°ŃĐž ĐœĐ° ĐșĐŸĐŒĐżĐŸĐœĐ”ĐœŃĐž, ŃĐ” ĐŽĐŸĐ·ĐČĐŸĐ»ŃŃ Đ·Đ±ŃĐ»ŃŃĐžŃĐž ĐżŃОбŃŃĐŸĐș ĐżŃĐŽĐżŃĐžŃĐŒŃŃĐČĐ°.ĐĐČĐ°Đ»ŃŃŃĐșĐ°ŃŃĐčĐœĐ° ŃĐŸĐ±ĐŸŃĐ° ŃŃŃĐżĐ”ĐœŃ Đ±Đ°ĐșалаĐČŃ ĐœĐ°ĐżŃŃĐŒŃ ĐżŃĐŽĐłĐŸŃĐŸĐČĐșĐž 124 ĐĄĐžŃŃĐ”ĐŒĐœĐžĐč Đ°ĐœĐ°Đ»ŃĐ·, ĐйУ "ĐĐœŃĐżŃĐŸĐČŃŃĐșĐ° ĐżĐŸĐ»ŃŃĐ”Ń
ĐœŃĐșĐ°", ĐŒ. ĐĐœŃĐżŃĐŸ, 2020 Ń.
ĐŃĐ°ĐșŃĐžŃĐœĐ° ŃŃĐœĐœŃŃŃŃ ŃĐŸĐ±ĐŸŃĐž ĐżĐŸĐ»ŃĐłĐ°Ń Ń ŃĐŸĐ·ŃĐŸĐ±ŃŃ ĐŒĐ°ŃĐ”ĐŒĐ°ŃĐžŃĐœĐžŃ
ĐŒĐŸĐŽĐ”Đ»Đ”Đč, ŃĐșŃ ĐŽĐŸĐ·ĐČĐŸĐ»ŃŃŃŃ ĐČĐžĐ·ĐœĐ°ŃĐžŃĐž ĐŸĐżŃĐžĐŒĐ°Đ»ŃĐœŃ ŃŃĐŒŃŃ ĐșĐŸŃĐŒŃ, ĐșĐŸŃŃĐ° бŃĐŽĐ” ĐČŃĐŽĐżĐŸĐČŃĐŽĐ°ŃĐž ĐœĐ”ĐŸĐ±Ń
ŃĐŽĐœĐžĐŒ ŃĐŒĐŸĐČĐ°ĐŒ
The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
This article contains supplemental material online at http://cjasn.
asnjournals.org/lookup/suppl/doi:10.2215/CJN.07730814/-/
DCSupplemental.BACKGROUND AND OBJECTIVES: The calcimimetic cinacalcet reduced the risk of death or cardiovascular (CV) events in older, but not younger, patients with moderate to severe secondary hyperparathyroidism (HPT) who were receiving hemodialysis. To determine whether the lower risk in younger patients might be due to lower baseline CV risk and more frequent use of cointerventions that reduce parathyroid hormone (kidney transplantation, parathyroidectomy, and commercial cinacalcet use), this study examined the effects of cinacalcet in older (â„65 years, n=1005) and younger (3-fold higher in younger relative to older patients and were more frequent in patients randomized to placebo. In older patients, the adjusted relative hazard (95% confidence interval) for the primary composite (CV) end point (cinacalcet versus placebo) was 0.70 (0.60 to 0.81); in younger patients, the relative hazard was 0.97 (0.86 to 1.09). Corresponding adjusted relative hazards for mortality were 0.68 (0.51 to 0.81) and 0.99 (0.86 to 1.13). Reduction in the risk of severe unremitting HPT was similar in both groups. CONCLUSIONS: In the EVOLVE trial, cinacalcet decreased the risk of death and of major CV events in older, but not younger, patients with moderate to severe HPT who were receiving hemodialysis. Effect modification by age may be partly explained by differences in underlying CV risk and differential application of cointerventions that reduce parathyroid hormone.The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial was funded by Amgen